Memorandum Of Association Of Pharmaceutical Company Template for England and Wales

When establishing a pharmaceutical company in England and Wales, you need a Memorandum of Association that specifically addresses the unique regulatory requirements of the pharmaceutical industry. This constitutional document serves as your company's foundational charter, defining its legal identity, scope of operations, and compliance framework under the Companies Act 2006. Unlike standard memoranda, pharmaceutical companies require carefully drafted objects clauses that encompass manufacturing, research, development, and distribution activities while ensuring alignment with MHRA regulations and GMP standards.

When do you need this document?

You must prepare this memorandum before incorporating any pharmaceutical company in England and Wales. It's essential when establishing companies engaged in drug manufacturing, pharmaceutical research and development, clinical trials, or medical device production. The document is required for MHRA licensing applications, as regulatory authorities need to verify that your company's constitutional documents permit pharmaceutical activities. You'll also need it when seeking investment from pharmaceutical industry investors, as they require assurance that your company is properly constituted to operate in this regulated sector. Additionally, this memorandum is necessary when applying for specialized pharmaceutical insurance or entering into manufacturing partnerships with established pharmaceutical companies.

Key legal considerations

The objects clause must be comprehensive enough to cover all intended pharmaceutical activities while remaining compliant with regulatory frameworks. You need to specify powers for manufacturing medicinal products, conducting clinical trials, obtaining regulatory approvals, and maintaining GMP compliance. The liability clause should clearly define members' limited liability, particularly important given the potential financial exposure in pharmaceutical operations including product liability claims. Share capital provisions must accommodate potential future funding rounds common in pharmaceutical ventures, including provisions for different classes of shares. The memorandum should also include powers to obtain necessary licenses from the MHRA, conduct research and development activities, and enter into collaboration agreements with universities, research institutions, and other pharmaceutical companies.

Legal requirements in England and Wales

Under the Companies Act 2006, your memorandum must state the company's name, registered office location in England and Wales, and confirm it's a private company limited by shares. The company name must comply with Companies House naming rules and avoid restricted terms without approval. Your objects clause must be drafted to satisfy both company law requirements and pharmaceutical regulatory expectations, ensuring activities align with the Medicines Act 1968 and Human Medicines Regulations 2012. The document must be signed by all subscribers in the presence of at least one witness, with each subscriber taking at least one share. You must file the memorandum with Companies House alongside Form IN01 and the Articles of Association, paying the required incorporation fee. The registered office must be a physical address in England and Wales where official correspondence can be received.